Max Higgins, Consultant, Author at EverGlade Consulting

Max Higgins, Consultant

Max Higgins, Consultant
ARPA-H BioStabilization Systems (BoSS) Program

ARPA-H Launches the BioStabilization Systems (BoSS) Program to Transform Cell Therapy Distribution

Leave a Comment / ARPA-H, Life Sciences / By

BOSS_ISO_Final_01Dec2025 The Advanced Research Projects Agency for Health (ARPA-H) has announced a landmark Innovative Solutions Opening (ISO) for the BioStabilization Systems (BoSS) program, an ambitious effort to revolutionize how live cell-based therapies are stabilized, manufactured, and distributed. As outlined in the solicitation, BoSS aims to eliminate the field’s dependence on ultra-cold storage and transport, which […]

ARPA-H Launches the BioStabilization Systems (BoSS) Program to Transform Cell Therapy Distribution Read More »

DARPA BAA Information Innovation

DARPA I2O Office-Wide BAA Opens the Door for Breakthroughs in Information Innovation

Leave a Comment / DARPA, Emerging Technologies / By

DARPA Broad Agency Announcement HR001126S0001 The Defense Advanced Research Projects Agency (DARPA), through its Information Innovation Office (I2O), has released its FY2026 Office-Wide Broad Agency Announcement (BAA) seeking groundbreaking research that can fundamentally reshape the nation’s capabilities across information science, cybersecurity, artificial intelligence (AI), and complex software systems. This solicitation, HR001126S0001, invites performers to propose

DARPA I2O Office-Wide BAA Opens the Door for Breakthroughs in Information Innovation Read More »

BARDA next generation vaccine platforms

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness

Leave a Comment / BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has released a new Request for Information (RFI) focused on “New Vaccine Platforms.” This solicitation seeks to better understand the current landscape of vaccine platform technologies capable

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness Read More »

ARPA-H Evident Program

ARPA-H’s EVIDENT Program to Transform Behavioral Health Intervention Research

Leave a Comment / ARPA-H, Life Sciences / By

ARPA-H-RFS-EVIDENT-TA-1-3-Exploratory_Clean ARPA-H’s EVIDENT Program Seeks Objective Clinical Endpoints for Rapid-Acting Behavioral Health Treatments (1) Mental and behavioral health disorders, including depression, anxiety, and addiction, affect about half of all Americans, with treatment costs nearing $200 billion annually.  Yet, traditional diagnostics still rely heavily on subjective endpoints that fail to capture the complexity and immediacy of

ARPA-H’s EVIDENT Program to Transform Behavioral Health Intervention Research Read More »

JPEO seeks next-generation genomic sequencing

JPEO-CBRND Seeks Next-Generation Genomic Sequencing for Defense Readiness

Leave a Comment / JPEO, Life Sciences / By

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has released a new Request for Information (RFI) focused on advancing end-to-end, untargeted genomic sequencing workflows for military use. As the Department of Defense (DoD) increases its emphasis on rapid biodefense decision-making, this RFI highlights the agency’s commitment to identifying technologies capable

JPEO-CBRND Seeks Next-Generation Genomic Sequencing for Defense Readiness Read More »

JPEO Innovation Biologics Manufacturing

JPEO-CBRND Seeks Innovation in Biologics Manufacturing

Leave a Comment / JPEO, Life Sciences / By

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has released a new Request for Information (RFI) focused on Innovation in Biologics Manufacturing, underscoring the organization’s mission to strengthen U.S. biodefense through next-generation bioproduction capabilities. As the premier program management office for enabling biotechnologies across the War Department, JPEO-CBRND aims to

JPEO-CBRND Seeks Innovation in Biologics Manufacturing Read More »

ARPA-H AIR

EverGlade Insights: ARPA-H Launches the Autonomous Interventions and Robotics (AIR) Program

Leave a Comment / ARPA-H, Life Sciences / By

AIR+ARPA-H-SOL-26-146+Amend+01 The Advanced Research Projects Agency for Health (ARPA-H) has released a major new Innovative Solutions Opening (ISO) titled Autonomous Interventions and Robotics (AIR), marking one of the most ambitious federal investments to date in autonomous surgical systems and micro-scale medical robotics. The program seeks to fundamentally redefine how clinicians diagnose and treat life-threatening conditions

EverGlade Insights: ARPA-H Launches the Autonomous Interventions and Robotics (AIR) Program Read More »

JPEO RFI for Faster CBRN Medical Countermeasures

JPEO-CBRND’s New Approach Methods RFI for Faster CBRN Medical Countermeasures

Leave a Comment / JPEO, Life Sciences / By

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense – Enabling Biotechnologies (JPEO-CBRND-EB) has released a Request for Information (RFI) on New Approach Methods (NAMs) to support medical countermeasure (MCM) development against chemical, biological, radiological, and nuclear (CBRN) threats. In line with broader efforts at the Food and Drug Administration (FDA) and

JPEO-CBRND’s New Approach Methods RFI for Faster CBRN Medical Countermeasures Read More »

JPEO RFI Wearable Sensors

JPEO-CBRND RFI: Wearable Sensors for Real-Time CBRN Threat Monitoring

Leave a Comment / JPEO, Life Sciences / By

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has released a new Request for Information (RFI) focused on advancing wearable Chem-Bio-Radiological-Nuclear (CBRN) monitoring technologies. As the Department of Defense (DoD) continues strengthening preparedness for complex, multi-domain threats, this RFI seeks industry input on next-generation wearable sensors capable of supporting warfighter

JPEO-CBRND RFI: Wearable Sensors for Real-Time CBRN Threat Monitoring Read More »

BARDA's ASSURE Program

BARDA’s ASSURE Program to Advance Next-Generation Immune Assays

Leave a Comment / BARDA, Life Sciences / By

RPPV-26-07-ASSURE-Amendment-1 The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR), has released a new opportunity under the Rapid Response Partnership Vehicle (RRPV): the Assay Development for Superior Understanding of Response and Efficacy (ASSURE) program. Designed to strengthen national health security, ASSURE seeks to accelerate the development

BARDA’s ASSURE Program to Advance Next-Generation Immune Assays Read More »

ARPA-H MOCS Initiative

ARPA-H Launches the Making Obstetric Care Smart (MOCS) Initiative

Leave a Comment / ARPA-H, Life Sciences / By

MOCS_ISO_Amend_+01_20251216 The Advanced Research Projects Agency for Health (ARPA-H) has released a major new Innovative Solutions Opening (ISO) titled Making Obstetric Care Smart (MOCS). This is a national effort to transform maternal and fetal health outcomes through advanced, data-driven technologies. As maternal morbidity and mortality rise across the United States, ARPA-H is calling on innovators

ARPA-H Launches the Making Obstetric Care Smart (MOCS) Initiative Read More »

BARDA pandemic influenza vaccine partnerships

BARDA Seeks Industry Input for Pandemic Influenza Vaccine Partnerships

Leave a Comment / BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has released a new Sources Sought Notice (SSN) and Request for Information (RFI) focused on vaccine medical countermeasures (MCMs) for pandemic influenza preparedness and response. This initiative underscores BARDA’s ongoing commitment to strengthening the nation’s biosecurity

BARDA Seeks Industry Input for Pandemic Influenza Vaccine Partnerships Read More »

Scroll to Top